Plasmid Manufacturing For Gene Therapies: An Outsourcing Partnership

With an increased demand for plasmids for targeted gene therapeutic delivery, partnering with a CDMO equipped with the capacity, expertise and equipment for plasmid DNA production is critical to ensuring a stable therapeutic supply.

Ajinomoto Bio-Pharma Services, an industry leader in microbial fermentation, discusses why optimizing, scaling-up and manufacturing plasmids are necessary for clinical to commercial program success and how their proven expertise and capabilities in cGMP production of biotherapeutics enable a strong, client-focused partnership, ensuring market success.

access the Webinar!

Get unlimited access to:

Trend and Thought Leadership Articles
Case Studies & White Papers
Extensive Product Database
Members-Only Premium Content
Welcome Back! Please Log In to Continue. X

Enter your credentials below to log in. Not yet a member of Outsourced Pharma? Subscribe today.

Subscribe to Outsourced Pharma X

Please enter your email address and create a password to access the full content, Or log in to your account to continue.


Subscribe to Outsourced Pharma

Ajinomoto Bio-Pharma Services